Bahram Valamehr, Chief R&D Officer at FATE THERAPEUTICS INC (FATE), sold 34,316 shares at $30.23 ($1.0M) on 2022-07-07, disclosed to the SEC on 2022-07-08.
Open-market sale of $1.0M FATE by Chief R&D Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.23 | 17,158 | $519K | 50.0% |
| 2 | $30.23 | 17,158 | $519K | 50.0% |
| Total | $30.23 avg | 34,316 | $1.0M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |